RCAP
Asset Logo

Resolution Cap Global Prop Sec (Managed Fund)

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ•Š๏ธ SOCIALLY AWARE

๐Ÿ  REAL ESTATE

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ“™ Holdings

๐Ÿ’ฐ Distributions

๐Ÿ’ต Cost

๐Ÿƒ Esg

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-1.83%
Annual Growth

5 years average annual growth

๐Ÿ’ฐ

1.82%
Annual distribution yield

Based on the most recent distribution

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

2
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

RCAP.AX was created on 2022-02-22 by Resolution Capital. The fund's investment portfolio concentrates primarily on real estate equity. The Fund aims to achieve an annual total return that exceeds the total return of the Benchmark after fees on a rolling 3 year basis

๐ŸŒ Website

๐Ÿ“ˆ Performance

Price History

+18.76%

1M

1Y

10Y

Graph

Table

How could long term investing grow your wealth?*

Based on an initial investment of

$

and recurring investments every

for

$

Your wealth could grow to...
$58,751.82

after 5 years

$111,001.94

after 10 years

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ“™ Top Holdings

Show more
Welltower Inc
8.43%
Unibail-Rodamco-Westfield Act. SIIC ET STES FONC.EUROP.
3.61%

Updated as of 30 September 2024

Industry Exposure
๐Ÿก Real Estate
100%
Country Exposure
๐Ÿ‡บ๐Ÿ‡ธ United States
85%
๐Ÿ‡ฆ๐Ÿ‡บ Australia
8%
๐Ÿ‡ซ๐Ÿ‡ท France
7%

๐Ÿ’ฐ Distributions

Payouts

๐Ÿ’ฐ Annual Distribution Yield*

1.82%

๐Ÿ’ฐ Annual Distribution Earnings Per $1,000 invested**

$18.22

๐Ÿ’ฐ Most Recent Distribution Franked Percentage Estimate

3.89%

๐Ÿ’ฐ Average Distribution Franked Percentage Estimate

1.83 %

๐Ÿ’ฐ Distribution reinvestment

Learn more

* Based on the most recent distribution

** Calculated by multiplying the most recent distribution yield by $1,000

Estimate your distribution

If you held

$

of RCAP, your last distribution payment(s) would have been:

$ 39.97

on Tue Oct 15 2024

$ 58.06

on Mon Jul 15 2024

*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.

Distribution History

1Y

5Y

10Y

Graph

Table

Year
Yearly Distribution Earnings Per Share
Franking Estimate

2024

$0.03

1.30%

2023

$0.04

0.20%

2022

$0.05

0.40%

2021

$0.00

0.00%

2020

$0.00

0.00%

2019

$0.00

0.00%

2018

$0.00

0.00%

2017

$0.00

0.00%

2016

$0.00

0.00%

2015

$0.00

0.00%

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

0.80%
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿƒ Environmental, Social and Governance scores โ„น๏ธ

๐ŸŒณ

Environmental Score
55

A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution

๐Ÿ•Š๏ธ

Social Score
99

An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.

โš–๏ธ

Governance Score
41

An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$1.70

๐Ÿ’ฐ Price To Earnings Ratio

0.00

๐Ÿ’ฐ Price To Book Ratio

0.00

๐Ÿ’ฐ Leveraged

No

๐Ÿ’ฐ Inverse

No

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in RCAP

2

๐Ÿ“Š Total Capital Earnings

$33K

๐Ÿ”ƒ Average investment frequency

33 weeks

๐Ÿ’ต Average investment amount

$3,955

โฐ Last time a customer invested in RCAP

90 days
RCAP investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

33%

50k - 100k

Less than 50k

67%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
๐Ÿ™‹ Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in RCAP also invest in...

ResMed Inc.

RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,140 full-time employees. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Companyโ€™s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

๐Ÿ™Œ Performance (5Yr p.a)

14.49%

๐Ÿ“Š Share price

$36.99 AUD

๐Ÿฉบ HEALTH CARE

๐ŸŒณ ENVIRONMENTAL

๐Ÿ•Š๏ธ SOCIALLY AWARE

๐Ÿ“ˆ HIGH PRICE GROWTH

Find Out More

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Companyโ€™s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Companyโ€™s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

๐Ÿ™Œ Performance (5Yr p.a)

1.88%

๐Ÿ“Š Share price

$283.99 AUD

๐Ÿ•Š๏ธ SOCIALLY AWARE

๐Ÿงฌ BIOTECHNOLOGY

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

๐Ÿ™Œ Performance (5Yr p.a)

13.00%

๐Ÿ“Š Share price

$15.13 AUD

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

๐Ÿ“ˆ HIGH PRICE GROWTH

โ›ณ๏ธ DIVERSIFIED

๐Ÿค– TECHNOLOGY

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 493.8m in AUM and 35 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

๐Ÿ™Œ Performance (5Yr p.a)

13.46%

๐Ÿ“Š Share price

$82.57 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

๐Ÿญ INDUSTRIALS

QUAL.AX was created on 2014-10-29 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. Each Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

๐Ÿ™Œ Performance (5Yr p.a)

18.12%

๐Ÿ“Š Share price

$55.06 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ“ž COMMUNICATIONS

๐Ÿ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

RCB.AX was created on 2012-03-08 by Russell. The fund's investment portfolio concentrates primarily on investment grade fixed income. The Fund aims to provide a total return before costs and tax, in line with DBIQ 0-4 year Investment Grade Australian Corporate Bond Index over the long term

๐Ÿ™Œ Performance (5Yr p.a)

-0.71%

๐Ÿ“Š Share price

$20.01 AUD

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

Recce Pharmaceuticals Ltd. is engaged in the research and development of pharmaceutical drugs that kill germs. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-01-15. The firm's anti-infective pipeline includes three broad-spectrum, synthetic polymer anti-infectives: RECCE 327 as an intravenous and topical therapy that is being developed for the treatment of serious and potentially life-threatening infections due to Gram-positive and Gram-negative bacteria including their superbug forms; RECCE 435 as an orally administered therapy for bacterial infections; and RECCE 529 for viral infections. Through their multi-layered mechanisms of action, the Company's anti-infectives have the potential to overcome the hypercellular mutation of bacteria and viruses. All RECCE compounds are water soluble at all pH levels in their liquid form.

๐Ÿ™Œ Performance (5Yr p.a)

13.82%

๐Ÿ“Š Share price

$0.47 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ“ฆ LOGISTICS

Redcastle Resources Ltd. develops a cloud-connected modern information system in a single application. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2003-03-21. The firm is focused on pursuing success at the 100% owned Redcastle Gold Project. The Redcastle Gold Project covers a prospective area of 1,088 hectares, surrounding the locality of the historical Redcastle Mining Centre within the Mt Morgans District of the Mt Margaret Mineral Field of Western Australia, approximately 60 kilometers (km) east of Leonora and 60 km west of Laverton in the North-eastern Goldfields. The Redcastle Project tenements consist of a mix of one granted mining lease, and various prospecting licenses. Its tenements include M39/318, P39/5184, P39/5307, P39/5568, P39/5573, P39/5814, P39/5815, P39/5858 and P39/6185.

๐Ÿ™Œ Performance (5Yr p.a)

7.50%

๐Ÿ“Š Share price

$0.01 AUD

โ›๏ธ MINING

๐Ÿ“Š Share price

$0.00 AUD
Compare
Add to watchlist